scholarly article | Q13442814 |
P50 | author | Christine L Le Maitre | Q39409436 |
Anthony J. Freemont | Q39979698 | ||
Stephen M Richardson | Q40727008 | ||
P2093 | author name string | Judith A Hoyland | |
Pauline Baird | |||
P2860 | cites work | Fibroblast growth factor receptor 3 is a negative regulator of bone growth | Q24322706 |
Aggrecan degradation in human intervertebral disc and articular cartilage | Q42987526 | ||
P433 | issue | 4 | |
P304 | page(s) | 445-452 | |
P577 | publication date | 2005-12-01 | |
P1433 | published in | Journal of Pathology | Q400296 |
P1476 | title | Expression of receptors for putative anabolic growth factors in human intervertebral disc: implications for repair and regeneration of the disc. | |
P478 | volume | 207 |
Q37333379 | A combinatorial relative mass value evaluation of endogenous bioactive proteins in three-dimensional cultured nucleus pulposus cells of herniated intervertebral discs: identification of potential target proteins for gene therapeutic approaches |
Q38207929 | An understanding of intervertebral disc development, maturation and cell phenotype provides clues to direct cell-based tissue regeneration therapies for disc degeneration. |
Q28267267 | Aquaporin expression in the human intervertebral disc |
Q38244571 | Biologic treatment of mild and moderate intervertebral disc degeneration |
Q33649899 | Biomechanical Conditioning Enhanced Matrix Synthesis in Nucleus Pulposus Cells Cultured in Agarose Constructs with TGFβ |
Q48732898 | CRISPR Epigenome Editing of AKAP150 in DRG Neurons Abolishes Degenerative IVD-Induced Neuronal Activation. |
Q38238933 | Cell and molecular biology of intervertebral disc degeneration: current understanding and implications for potential therapeutic strategies |
Q34532783 | Changes in the molecular phenotype of nucleus pulposus cells with intervertebral disc aging |
Q33633881 | Different Expression of Extracellular Matrix Genes : Primary vs. Recurrent Disc Herniation |
Q37454079 | Expression of cartilage-derived morphogenetic protein in human intervertebral discs and its effect on matrix synthesis in degenerate human nucleus pulposus cells |
Q35550872 | Growth factors and anticatabolic substances for prevention and management of intervertebral disc degeneration |
Q38344714 | Growth factors and platelet-rich plasma: promising biological strategies for early intervertebral disc degeneration |
Q46107026 | Growth factors in intervertebral disc homeostasis |
Q34075913 | Histological analysis of surgical lumbar intervertebral disc tissue provides evidence for an association between disc degeneration and increased body mass index |
Q37372115 | Human umbilical cord mesenchymal stromal cells exhibit immature nucleus pulposus cell phenotype in a laminin-rich pseudo-three-dimensional culture system |
Q42056281 | Identifying molecular phenotype of nucleus pulposus cells in human intervertebral disc with aging and degeneration |
Q35164320 | Imbalanced protein expression patterns of anabolic, catabolic, anti-catabolic and inflammatory cytokines in degenerative cervical disc cells: new indications for gene therapeutic treatments of cervical disc diseases |
Q51654787 | Inhibiting IL-1 signaling pathways to inhibit catabolic processes in disc degeneration. |
Q36392408 | Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study |
Q36508661 | Mesenchymal stem cells: potential application in intervertebral disc regeneration. |
Q38179426 | Molecular therapy for disk degeneration and pain |
Q51760394 | Novel therapeutic strategies for degenerative disc disease: Review of cell biology and intervertebral disc cell therapy. |
Q35038528 | Nucleus pulposus cells derived IGF-1 and MCP-1 enhance osteoclastogenesis and vertebrae disruption in lumbar disc herniation |
Q36421205 | PDGF, bFGF and IGF-I stimulate the proliferation of intervertebral disc cells in vitro via the activation of the ERK and Akt signaling pathways |
Q36545845 | Prevention of disc degeneration with growth factors |
Q50918368 | Reduced expression of insulin-like growth factor 1 receptor leads to accelerated intervertebral disc degeneration in mice. |
Q35144834 | Role of growth differentiation factor-5 and bone morphogenetic protein type II receptor in the development of lumbar intervertebral disc degeneration |
Q42466481 | Roles of FGF-2 and TGF-beta/FGF-2 on differentiation of human mesenchymal stem cells towards nucleus pulposus-like phenotype |
Q89641788 | Stem cell therapy in discogenic back pain |
Q54242759 | TGF-β3 and IGF-1 synergy ameliorates nucleus pulposus mesenchymal stem cell differentiation towards the nucleus pulposus cell type through MAPK/ERK signaling. |
Q30413330 | The challenge and advancement of annulus fibrosus tissue engineering |
Q33706077 | Wnt signaling activates Shh signaling in early postnatal intervertebral discs, and re-activates Shh signaling in old discs in the mouse |
Search more.